FIELD: medicine.
SUBSTANCE: group of inventions relates to treating acute central nervous system damage. Disclosed is the use of a specific hexokinase-2 inhibitor for preparing a drug for preventing or treating acute central nervous system damage, mediated by activation of microglia. Also disclosed is use of a composition containing a specific hexokinase-2 inhibitor, for preparing a drug for preventing and treating acute central nervous system damage mediated by activation of microglia.
EFFECT: group of inventions provides neuroprotective action.
9 cl, 9 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF THE COMPOUND FOR THE PREPARATION OF A DRUG FOR THE TREATMENT OF CEREBRAL MICROANGIOPATHY | 2018 |
|
RU2752089C1 |
| PEPTIDE COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE | 2021 |
|
RU2816119C1 |
| METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS | 2003 |
|
RU2353385C2 |
| FUSED MOLECULE CAPABLE OF INDUCING NON-INFLAMMATORY PHAGOCYTOSIS | 2022 |
|
RU2823919C1 |
| RECOMBINANT CHIMERIC PROTEIN OF NEUTROPHIL AND GIRUGEN INHIBITION FACTOR AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2008 |
|
RU2426745C2 |
| TREATMENT OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO BDNF | 2013 |
|
RU2661104C2 |
| THERAPEUTIC AGENT FOR TREATING NERVOUS SYSTEM DISEASE | 2018 |
|
RU2825666C2 |
| METHOD FOR CORRECTING POSTISCHEMIC COGNITIVE DYSFUNCTION | 2006 |
|
RU2315618C1 |
| METHODS AND APPLICATIONS INCLUDING HEME PROTEIN 1 | 2009 |
|
RU2520748C2 |
| COMPOSITION FOR NEUROPROTECTION AND STIMULATION OF BRAIN NEUROREGENERATION AFTER INJURY, AGENT BASED ON IT, A METHOD OF ITS PRODUCTION AND USE | 2022 |
|
RU2803286C1 |
